India recommends Covaxin vs Covid-19 vaccine for children 2 years of age and older | Vaccines
1 min read
a India On Tuesday (12) it recommended the emergency use of the Covid-19 vaccine from Bharat Biotech for the age group of 2 to 18 years, as the world’s second most populous country expands its vaccination campaign to include children.
The country has vaccinated about 29% of 944 million eligible adults, according to government data, which includes the application of more than 110 million doses of Covaxin, from Bharat Biotech.
However, the company is still in the process of securing its name on the World Health Organization’s emergency use list, a decision expected later this month.
Without WHO approval, the two-dose vaccine is unlikely to be accepted as a valid vaccine worldwide.
Several countries have worked to license vaccines for children. The US has released the Pfizer vaccine for children 12 years of age and older, and the US regulator’s advisory committee will meet later this month to discuss the vaccine for children ages 5 to 11.
Although Covid-19 is known to generally cause mild illness in children, there is a risk of rare complications after illness.
“Children with comorbidities should be vaccinated as soon as possible now that a vaccine with pediatric immunity and a large adult safety database is available,” said Dr. Jagandeep Kang, professor at Christian Medical College, Vellore.
Videos: G1 most viewed in the last 7 days
“Devoted food specialist. General alcohol fanatic. Amateur explorer. Infuriatingly humble social media scholar. Analyst.”
